Lovenox (enoxaparin sodium) NDC 0075-0623

NDC codes

FDA NDC Directory

Product NDC (as listed)0075-0623Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00075-0623Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0075-0623-00	00075062300	10 CELLO PACK in 1 CARTON (0075-0623-00) / 1 SYRINGE in 1 CELLO PACK (0075-0623-03) / 1 mL in 1 SYRINGEMarketed from Mar 29, 1993

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lovenox
Generic name (nonproprietary): enoxaparin sodium
Active ingredients: Enoxaparin sodium — 100 mg/mL
Dosage form: Injection
Route: Subcutaneous
Labeler: Sanofi-Aventis U.S. LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020164
Marketing start: Mar 29, 1993
Listing expires: Dec 31, 2027
Other FDA classes: Low-Molecular-Weight (Chemical structure)
Identifiers: Product ID 0075-0623_cdb74d6d-1a74-4156-a52a-710c55cb2927SPL ID cdb74d6d-1a74-4156-a52a-710c55cb2927SPL set ID 5017a927-2a24-4f27-89f9-27c805bf7d59RxCUI 854228, 854232, 854235, 854236, 854238, 854239, 854241, 854242, 854245, 854247, 854248, 854249, 854252, 854253, 854255, 854256UNII 8NZ41MIK1O
Pharmacologic class: Low Molecular Weight Heparin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400075062300 followed by a unit qualifier and the quantity

Package 00075-0623-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 28, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Lovenox is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness ( 1.1 ) Inpatient treatment of acute DVT with or without pulmonary embolism ( 1.2 ) Outpatient treatment of acute DVT without pulmonary embolism ( 1.2 ) Prophylaxis of ischemic complications of unstable angina and non–Q-wave myocardial infarction (MI) ( 1.3 ) Treatment of acute ST-segment elevation myocardial infarction (STEMI) managed medically or with subsequent percutaneous coronary intervention (PCI) ( 1.4 ) 1.1 Prophylaxis of Deep Vein T…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020164

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020164
Product	Strength	Form · route	Labeler	Product NDC
Lovenoxenoxaparin sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0075-2915
Enoxaparin sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1010
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-605
Lovenoxenoxaparin sodium	Enoxaparin sodium 80 mg/.8mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0075-0622
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-605
Enoxaparin Sodium	Enoxaparin sodium 120 mg/.8mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-609
Enoxaparin Sodium	Enoxaparin sodium 60 mg/.6mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-607
Enoxaparin Sodium	Enoxaparin sodium 60 mg/.6mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-607
Enoxaparin Sodium	Enoxaparin sodium 120 mg/.8mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-609
Enoxaparin sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1004
Lovenoxenoxaparin sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0075-8014
Enoxaparin sodium	Enoxaparin sodium 60 mg/.6mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1006
Enoxaparin sodium	Enoxaparin sodium 80 mg/.8mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1008
Lovenoxenoxaparin sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0075-0620
Lovenoxenoxaparin sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Cardinal Health 107, LLC	55154-4028
Enoxaparin sodium	Enoxaparin sodium 120 mg/.8mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1012
Lovenoxenoxaparin sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0075-8025
Enoxaparin sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1015
Enoxaparin sodium	Enoxaparin sodium 300 mg/3mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1016
Lovenoxenoxaparin sodium	Enoxaparin sodium 300 mg/3mL	InjectionIntravenous, Subcutaneous	Sanofi-Aventis U.S. LLC	0075-0626

Showing 20 of 39.